Reimbursement: Wave Goodbye To $200 Million Next Year

Why This Topic Matters

The changes described affect how physicians are paid for services, drug administration, and oncology-related care under Medicare. Practices that bill these services need to understand the policy updates to anticipate reimbursement impacts and reporting changes.

Article Sections

1. Payment update overview

   Introduces the 2005 Medicare physician fee schedule and summarizes the broad categories of reimbursement changes discussed in the article. It provides the overall context for physician services, drugs, and related billing issues.

2. Drug payment methodology and CMS rationale

   Explains the Medicare approach to drug payment updates and the agency's stated reason for revising payment policy. It also frames the impact on services associated with drug delivery.

3. New injection codes and status indicator changes

   Describes the upcoming changes affecting injection administration reporting and the replacement of earlier HCPCS entries. It focuses on the categories of codes involved and the payment-status update.

4. Oncology demonstration project

   Summarizes the planned one-year Medicare demonstration for oncologists and the general reporting areas included in the project. It places the initiative in the context of oncology reimbursement and supportive care documentation.

5. Estimated impact on cancer care reimbursement

   Presents the article's discussion of the expected financial effect on cancer care and how the new policies may offset part of the reductions. It reflects the overall budgetary significance for oncology practices.